You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thrombocythemia

Showing 51 - 75 of 328
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Thrombocythemia, Hemorrhagic Trial in Worldwide (Anagrelide, Hydroxyurea)

Completed
Has Results
  • Thrombocythemia, Hemorrhagic
  • Pleven, Bulgaria
  • +14 more
May 13, 2021

Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)

Completed
Has Results
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Phoenix, Arizona
  • +12 more
Jan 12, 2021

Patients With ET Treated With XAGRID®

Completed
Has Results
  • Essential Thrombocythemia (ET)
  • Anagrelide hydrochloride
  • Bari, Italy
  • +9 more
Jul 6, 2021

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +61 more
May 5, 2022

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

Recruiting
  • Polycythemia Vera (PV)
  • P1101 (Ropeginterferon alfa-2b)
  • Toon-shi, Ehime, Japan
  • +5 more
Jun 13, 2022

Xagrid (FOX) Study In Adult Essential Thrombocythemia

Completed
Has Results
  • Essential Thrombocythemia
    • Paris, Cedex 13, France
    • +45 more
    Jun 7, 2021

    Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

    Recruiting
    • Myelofibrosis Transformation in Essential Thrombocythemia
    • +2 more
    • Elotuzumab
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 17, 2021

    Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

    Recruiting
    • Myelofibrosis
    • +5 more
    • Birmingham, Alabama
    • +27 more
    Oct 17, 2022

    Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

    Unknown status
    • Essential Thrombocythemia
    • +2 more
    • Diagnostic (18F-FLT PET/CT)
    • Doha, Qatar
      National Center for Cancer Care & Research (NCCCR)
    Sep 27, 2020

    Myelofibrosis Trial in Worldwide (Ruxolitinib)

    Completed
    Has Results
    • Myelofibrosis
    • Winter Park, Florida
    • +17 more
    Jan 10, 2022

    Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

    Recruiting
    • Essential Thrombocythemia
    • Phoenix, Arizona
    • +60 more
    Dec 30, 2021

    Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)

    Terminated
    Has Results
    • Myelofibrosis
    • Stanford, California
    • +1 more
    Aug 31, 2020

    Polycythaemia Vera and Essential Thrombocythaemia: Influence on

    Completed
    • Polycythemia Vera
    • Thrombocythemia, Essential
    • No cytoreductive vs cytoreductive drugs
    • Geneva, Switzerland
    • +1 more
    Nov 9, 2020

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

    Recruiting
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Glendale, California
    • +28 more
    May 5, 2022

    Essential Thrombocythaemia Trial in Spain, Sweden, United Kingdom (anagrelide HCl)

    Completed
    Has Results
    • Essential Thrombocythaemia
    • anagrelide hydrochloride
    • Barcelona, Spain
    • +4 more
    Jun 7, 2021

    Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Jul 9, 2021

    Myelofibrosis Trial in United States (Simtuzumab, Ruxolitinib)

    Completed
    Has Results
    • Myelofibrosis
    • Scottsdale, Arizona
    • +6 more
    Jun 17, 2020

    Myelofibrosis Trial in Rochester, Firenze (APLIDIN (plitidepsin))

    Completed
    Has Results
    • Myelofibrosis
    • APLIDIN (plitidepsin)
    • Rochester, Minnesota
    • +1 more
    Sep 17, 2020

    Polycythemia Vera, Essential Thrombocythemia Trial in Worldwide (Momelotinib)

    Terminated
    • Polycythemia Vera
    • Essential Thrombocythemia
    • Scottsdale, Arizona
    • +14 more
    Apr 14, 2020

    Endoplasmic Reticulum Stress and Resistance to Treatments in

    Completed
    • Polycythemia Vera
    • Essential Thrombocythemia
    • RNA sample of total leukocytes before start of treatment
    • Angers, France
    • +6 more
    Jun 18, 2020

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Birmingham, Alabama
    • +151 more
    Aug 22, 2022

    Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)

    Active, not recruiting
    • Polycythemia Vera (PV)
    • Essential Thrombocythemia (ET)
    • Mannheim, Baden-Württemberg, Germany
    • +23 more
    Oct 6, 2020